Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -14.55% vs -0.16% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -56.41% vs 26.51% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -69.30% vs 31.15% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 8.77% vs 21.28% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Apeloa Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -14.55% vs -0.16% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -18.94% vs 12.41% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -56.41% vs 26.51% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -43.97% vs -2.24% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -69.30% vs 31.15% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -64.11% vs 7.86% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 8.77% vs 21.28% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.89% vs -30.10% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






